StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.50−0.90 (-2.54%)

Close on Nov 17, 2026Market cap $2.57BP/E –Yield –

Xencor EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Xencor's EV/EBITDA was 31.6× on Jan 31, 2023, against 62.5× a year earlier. Over the last 3 years it ranged from 13.3× to 72.8×, with a median of 28.5×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 202331.6×+6.8
2022Dec 30, 202224.9×−37.7
2020Apr 30, 202062.5×+11.1
2019Dec 31, 201951.5×−13.0
2017Jul 31, 201764.5×+40.8
2016Dec 30, 201623.7×–

More Xencor figures

See a number that looks wrong?